The Orthofix SpinalStim you’re seeing here ... which seems to have been a problem on older bone stimulators. While I’m disappointed the SpinalStim swallowed its cyanide pill rather than ...

Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $17 ...

StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...

The analyst is optimistic about Orthofix Medical's unique offerings ... and further penetration in existing accounts, 9% growth in Bone Growth Therapies net sales and 13% growth in BGT Fracture ...

report_id=AMR706 The global bone growth stimulators market is highly competitive, with a number of established players as well as new entrants vying for market share. Key players in the market include ...